Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ALVR

AlloVir (ALVR)

AlloVir Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ALVR
DateTimeSourceHeadlineSymbolCompany
01/17/20253:11PMEdgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:ALVRAlloVir Inc
01/15/20253:41PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ALVRAlloVir Inc
01/15/20253:39PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALVRAlloVir Inc
01/10/20254:01PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ALVRAlloVir Inc
01/10/20254:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALVRAlloVir Inc
01/10/20256:44AMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ALVRAlloVir Inc
01/10/20256:42AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALVRAlloVir Inc
12/20/20243:23PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ALVRAlloVir Inc
12/20/20243:21PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALVRAlloVir Inc
12/09/20245:37AMEdgar (US Regulatory)Form S-4 - Registration of securities, business combinationsNASDAQ:ALVRAlloVir Inc
12/06/20248:50PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ALVRAlloVir Inc
12/06/20246:23AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ALVRAlloVir Inc
11/26/20243:33PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ALVRAlloVir Inc
11/20/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
11/19/20247:00PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
11/08/20243:13PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ALVRAlloVir Inc
11/08/20243:10PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ALVRAlloVir Inc
11/08/20243:09PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ALVRAlloVir Inc
11/08/20243:06PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ALVRAlloVir Inc
11/08/20243:05PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ALVRAlloVir Inc
11/08/20247:33AMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ALVRAlloVir Inc
11/08/20247:26AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALVRAlloVir Inc
11/06/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
11/05/20247:00PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
10/23/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
10/21/20247:00PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
10/11/20243:02PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ALVRAlloVir Inc
10/04/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
10/03/20247:00PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
08/22/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
 Showing the most relevant articles for your search:NASDAQ:ALVR